SOTERINIM Trademark

Trademark Overview

On Thursday, April 30, 2020, a trademark application was filed for SOTERINIM with the United States Patent and Trademark Office. The USPTO has given the SOTERINIM trademark a serial number of 88895919. The federal status of this trademark filing is ABANDONED - NO STATEMENT OF USE FILED as of Monday, October 30, 2023. This trademark is owned by Pfizer Inc.. The SOTERINIM trademark is filed in the Pharmaceutical Products category with the following description:

Pharmaceutical preparations for the treatment of autoimmune, cardiovascular, central nervous system, endocrine, gastrointestinal, genetic, infectious, inflammatory, kidney, liver, menopausal, metabolic, musculoskeletal, neurodegenerative, neurological, neuromuscular and viral diseases and disorders; pharmaceutical preparations for the treatment of blood disorders, bone growth disorders, skin disorders, arthritis, cancer, hypertension, pain, stroke, obesity and diabetes; pharmaceutical preparations, namely, anti-infective preparations, medicated dermatological preparations and smoking cessation preparations; vaccines for human use
soterinim

General Information

Serial Number88895919
Word MarkSOTERINIM
Filing DateThursday, April 30, 2020
Status606 - ABANDONED - NO STATEMENT OF USE FILED
Status DateMonday, October 30, 2023
Registration Number0000000
Registration DateNOT AVAILABLE
Mark Drawing4000 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateTuesday, August 4, 2020

Trademark Statements

Goods and ServicesPharmaceutical preparations for the treatment of autoimmune, cardiovascular, central nervous system, endocrine, gastrointestinal, genetic, infectious, inflammatory, kidney, liver, menopausal, metabolic, musculoskeletal, neurodegenerative, neurological, neuromuscular and viral diseases and disorders; pharmaceutical preparations for the treatment of blood disorders, bone growth disorders, skin disorders, arthritis, cancer, hypertension, pain, stroke, obesity and diabetes; pharmaceutical preparations, namely, anti-infective preparations, medicated dermatological preparations and smoking cessation preparations; vaccines for human use

Classification Information

International Class005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
US Class Codes006, 018, 044, 046, 051, 052
Class Status Code6 - Active
Class Status DateWednesday, May 13, 2020
Primary Code005
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

Trademark Owner History

Party NamePfizer Inc.
Party Type20 - Owner at Publication
Legal Entity Type03 - Corporation
AddressNew York, NY 100012192
Party NamePfizer Inc.
Party Type10 - Original Applicant
Legal Entity Type03 - Corporation
AddressNew York, NY 10017

Trademark Events

Event DateEvent Description
Monday, October 30, 2023ABANDONMENT NOTICE E-MAILED - NO USE STATEMENT FILED
Monday, October 30, 2023ABANDONMENT - NO USE STATEMENT FILED
Monday, March 27, 2023APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED
Monday, March 27, 2023TEAS CHANGE OF CORRESPONDENCE RECEIVED
Monday, March 27, 2023ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
Monday, March 27, 2023TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
Monday, March 27, 2023TEAS CHANGE OF OWNER ADDRESS RECEIVED
Thursday, February 23, 2023NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Wednesday, February 22, 2023SOU EXTENSION 5 GRANTED
Monday, February 6, 2023SOU EXTENSION 5 FILED
Wednesday, February 22, 2023CASE ASSIGNED TO INTENT TO USE PARALEGAL
Monday, February 6, 2023SOU TEAS EXTENSION RECEIVED
Thursday, August 4, 2022NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Tuesday, August 2, 2022SOU EXTENSION 4 GRANTED
Tuesday, August 2, 2022SOU EXTENSION 4 FILED
Tuesday, August 2, 2022SOU TEAS EXTENSION RECEIVED
Friday, February 11, 2022NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Wednesday, February 9, 2022SOU EXTENSION 3 GRANTED
Wednesday, February 9, 2022SOU EXTENSION 3 FILED
Wednesday, February 9, 2022SOU TEAS EXTENSION RECEIVED
Thursday, August 5, 2021NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Tuesday, August 3, 2021SOU EXTENSION 2 GRANTED
Tuesday, August 3, 2021SOU EXTENSION 2 FILED
Tuesday, August 3, 2021SOU TEAS EXTENSION RECEIVED
Wednesday, February 3, 2021NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Monday, February 1, 2021SOU EXTENSION 1 GRANTED
Monday, February 1, 2021SOU EXTENSION 1 FILED
Monday, February 1, 2021SOU TEAS EXTENSION RECEIVED
Tuesday, September 29, 2020NOA E-MAILED - SOU REQUIRED FROM APPLICANT
Tuesday, August 4, 2020OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Tuesday, August 4, 2020PUBLISHED FOR OPPOSITION
Wednesday, July 15, 2020NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Thursday, June 25, 2020APPROVED FOR PUB - PRINCIPAL REGISTER
Tuesday, June 23, 2020ASSIGNED TO EXAMINER
Wednesday, May 13, 2020NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Monday, May 4, 2020NEW APPLICATION ENTERED

Related Keywords

soterinim preparations disorders pharmaceutical treatment hypertension pain stroke cancer growth bone